Amarin Corporation plc (AMRN)

NASDAQ: AMRN · Real-Time Price · USD

14.74

+0.10 (0.68%)

At close: Apr 2, 2026, 4:00 PM EDT

14.85

+0.11 (0.75%)

After-hours: Apr 2, 2026, 7:38 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Development and Commercialization of Vascepa	213.65M	228.61M	306.91M	369.19M	583.19M
Development and Commercialization of Vascepa Growth	-6.55%	-25.51%	-16.87%	-36.69%	-5.03%
Total	213.65M	228.61M	306.91M	369.19M	583.19M
Total Growth	-6.55%	-25.51%	-16.87%	-36.69%	-5.03%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
US	154.14M	166.70M	273.89M	-	-
US Growth	-7.54%	-39.13%	-	-	-
Europe	18.37M	13.66M	3.28M	-	-
Europe Growth	34.46%	316.08%	-	-	-
Rest of the World	10.24M	24.23M	8.13M	-	-
Rest of the World Growth	-57.73%	198.01%	-	-	-
Unallocated	30.89M	24.02M	21.61M	-	-
Unallocated Growth	28.59%	11.16%	-	-	-
Total	213.65M	228.61M	306.91M	-	-
Total Growth	-6.55%	-25.51%	-	-	-

Source: S&P Global Market Intelligence.